* Definitive Healthcare Corp DH.OQ DH.O is expected
to report
results on February 23.
* The Framingham Massachusetts-based company is expected to
report revenue of $44.621 million, according to the mean
estimate from 10 analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Definitive
Healthcare
Corp is for earnings of 4 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 6
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Definitive
Healthcare Corp is $40, about 45.1% above its last closing
price of $21.98.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2021 0.02 0.02 0.01 Missed -47.4
2021
This summary was machine generated February 22 at 03:01 GMT.
All figures in US dollars unless otherwise stated